Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 01-2012 | 10-2011 | 07-2011 | 04-2011 | 01-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,111 | -4,387 | -2,037 | -3,802 | -1,060 |
| Depreciation Amortization | 65 | 49 | 29 | 42 | 30 |
| Accounts receivable | 88 | -247 | -651 | -493 | -319 |
| Accounts payable and accrued liabilities | 43 | -286 | -82 | 636 | 1,139 |
| Other Working Capital | 84 | -533 | -364 | 536 | -44 |
| Other Operating Activity | 2,127 | 2,113 | 1,570 | 3,027 | 758 |
| Operating Cash Flow | $-3,704 | $-3,291 | $-1,535 | $-54 | $504 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -371 | -160 | -95 | -84 | -47 |
| Investing Cash Flow | $-371 | $-160 | $-95 | $-84 | $-47 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 98 | 98 | 4 | 9,116 | 2 |
| Common Stock Repurchased | N/A | N/A | N/A | -1,033 | -73 |
| Financing Cash Flow | $98 | $98 | $4 | $8,083 | $-71 |
| Exchange Rate Effect | 2 | 15 | 8 | -60 | -17 |
| Beginning Cash Position | 10,457 | 10,457 | 10,457 | 2,572 | 2,572 |
| End Cash Position | 6,482 | 7,119 | 8,839 | 10,457 | 2,941 |
| Net Cash Flow | $-3,975 | $-3,338 | $-1,618 | $7,885 | $369 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,704 | -3,291 | -1,535 | -54 | 504 |
| Capital Expenditure | -371 | -160 | -95 | -85 | -47 |
| Free Cash Flow | -4,075 | -3,451 | -1,630 | -139 | 457 |